Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets

Only 1 in 11 gets Covaxin as Bharat Biotech falls short of production targets Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has managed to get the first indigenous vaccine. Bharat Biotech, which manufactures it, has failed to ramp up production at the pace it had envisaged. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018